India News4 years ago
Bharat Biotech says Covaxin shows 81% efficacy in phase-3 trials
Much-awaited phase 3 trial results of Bharat Biotech's Covaxin were announced on Wednesday, which showed an interim efficacy of 81% in preventing the infection after administration...